JNJ-64530440

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64530440, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-64530440 in Healthy Japanese Male Participants [Phase 1]